The table below shows Taysha Gene Therapies, Inc.'s income statement by quarter, as reported in the company's quarterly filings. All figures are in US dollars; negative values appear in red.
Line item
Q1 2026
Q3 2025
Q2 2025
Q1 2025
Q3 2024
Q2 2024
Revenue
$0.00
$0.00
$1.99M
$2.30M
$1.79M
$1.11M
Cost of revenue
-
-
-
-
-
-
Gross profit
-
-
-
-
-
-
R&D
$33.81M
$25.75M
$20.14M
$15.56M
$14.95M
$15.07M
SG&A
TSHA annual revenue (10-K history)
Taysha Gene Therapies, Inc. reported annual revenue of $9.77M for fiscal year 2025. That is up 17.3% from $8.33M in fiscal 2024. Figures come from the company's audited annual reports as filed with the SEC.